Showing 6,421 - 6,440 results of 17,996 for search '(( significant concern decrease ) OR ( significant ((a decrease) OR (step decrease)) ))', query time: 0.81s Refine Results
  1. 6421

    Landmark detailed analysis of the cranium and mandibular phenotypes in Dp(16)1Yey. by José Tomás Ahumada Saavedra (22290934)

    Published 2025
    “…(B) Form difference matrix analysis: FDM Bootstrap with 10,000 iterations showing significant changes in Form (p = 0.008). The FDM confidence interval graph shows a decrease of more than 90% of the distances measured. …”
  2. 6422
  3. 6423
  4. 6424

    Cued-attention is mediated by a cholinergic HDB to SAC circuit. by Rahul Garg (3064578)

    Published 2025
    “…Inset denotes glomeruli with significant changes with SAC inhibition. Yellow: increased, dark grey: decreased, light grey: unchanged. …”
  5. 6425

    Data Sheet 1_From court to community: a cost–benefit evaluation of a community sports programme for Arab women in Israel's multiethnic context.docx by Limor Dina Gonen (14258380)

    Published 2025
    “…</p>Results<p>Mamanet participation was associated with improvements in physical health outcomes, including a significant reduction in psychosomatic symptoms (p < 0.001, effect size = 0.75). …”
  6. 6426

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  7. 6427

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  8. 6428

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  9. 6429

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  10. 6430

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  11. 6431

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  12. 6432

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  13. 6433

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
  14. 6434
  15. 6435

    Image 1_Cerebral small vessel disease as a possibly immune-related adverse event of immunotherapy in lung cancer patients: a retrospective study.tif by Na Wu (240778)

    Published 2025
    “…In Survival Analysis, CSVD did not show a significant impact on the median progression-free survival (PFS) and overall survival (OS) of lung cancer patients.…”
  16. 6436

    Table_1_Elevated serum albumin-to-creatinine ratio as a protective factor on clinical outcomes among critically ill patients with sepsis: a retrospective study.DOCX by Zhenkui Hu (11276526)

    Published 2024
    “…For each 1-unit increase in ACR, there was a 1.203-fold decrease in the risk of death during the hospital stay. …”
  17. 6437
  18. 6438
  19. 6439

    Data extraction. by Stefanie Lentner (21493018)

    Published 2025
    “…The detrimental impacts of decreased occupational balance are increasingly acknowledged, and interventions are emerging. …”
  20. 6440

    Characteristics of included studies. by Stefanie Lentner (21493018)

    Published 2025
    “…The detrimental impacts of decreased occupational balance are increasingly acknowledged, and interventions are emerging. …”